Researchers from Columbus Children's Hospital report details of new studies and findings in the area of Behcet disease
2007 NOV 14 -- "Behcet's disease (BD) is a systemic vasculitis that may involve a variety of organs. We describe a girl with oculocutaneous albinism (OCA) who, on initial evaluation for popliteal artery occlusion, was noted to have multiple cardiac thrombi," researchers in the United States report. "She later developed hemoptysis, which was the result of bilateral pulmonary artery aneurysms. Her clinical picture was consistent with BD. She was initially treated with prednisone and cyclophosphamide, followed by maintenance therapy with infliximab," wrote L.M. Endo and colleagues, Columbus Children's Hospital. The researchers concluded: "This case describes a unique patient with OCA who developed BD with large pulmonary aneurysms and has remained stable for over 1 year while receiving infliximab." Endo and colleagues published their study in Clinical Rheumatology (Pulmonary aneurysms and intracardiac thrombi due to Behcet's disease in an African-American adolescent with oculocutaneous albinism. Clinical Rheumatology, 2007;26(9):1537-1539). For additional information, contact T.P. Atkinson, Columbus Children's Hospital, 1600 7th Avenue S, Birmingham, AL 35233, USA. Publisher contact information for the journal Clinical Rheumatology is: Springer, 233 Spring Street, New York, NY 10013, USA. Keywords: United States, Birmingham, Behcet Disease, Behcet Syndrome, Rheumatology, Columbus Children's Hospital. This article was prepared by Immunotherapy Weekly editors from staff and other reports. Copyright 2007, Immunotherapy Weekly via NewsRx.com.
|
